These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33834622)

  • 1. Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an "HHT-like" syndrome in children.
    Hodgson J; Ruiz-Llorente L; McDonald J; Quarrell O; Ugonna K; Bentham J; Mason R; Martin J; Moore D; Bergstrom K; Bayrak-Toydemir P; Wooderchak-Donahue W; Morrell NW; Condliffe R; Bernabeu C; Upton PD
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1685. PubMed ID: 33834622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of
    Hodgson J; Swietlik EM; Salmon RM; Hadinnapola C; Nikolic I; Wharton J; Guo J; Liley J; Haimel M; Bleda M; Southgate L; Machado RD; Martin JM; Treacy CM; Yates K; Daugherty LC; Shamardina O; Whitehorn D; Holden S; Bogaard HJ; Church C; Coghlan G; Condliffe R; Corris PA; Danesino C; Eyries M; Gall H; Ghio S; Ghofrani HA; Gibbs JSR; Girerd B; Houweling AC; Howard L; Humbert M; Kiely DG; Kovacs G; Lawrie A; MacKenzie Ross RV; Moledina S; Montani D; Olschewski A; Olschewski H; Ouwehand WH; Peacock AJ; Pepke-Zaba J; Prokopenko I; Rhodes CJ; Scelsi L; Seeger W; Soubrier F; Suntharalingam J; Toshner MR; Trembath RC; Vonk Noordegraaf A; Wort SJ; Wilkins MR; Yu PB; Li W; Gräf S; Upton PD; Morrell NW
    Am J Respir Crit Care Med; 2020 Mar; 201(5):575-585. PubMed ID: 31661308
    [No Abstract]   [Full Text] [Related]  

  • 3. A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: Does BMP10 status contribute?
    Upton P; Richards S; Bates A; Niederhoffer KY; Morrell NW; Christian S
    Am J Med Genet A; 2023 Jan; 191(1):228-233. PubMed ID: 36259599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary vascular phenotype identified in patients with
    Grynblat J; Bogaard HJ; Eyries M; Meyrignac O; Savale L; Jaïs X; Ghigna MR; Celant L; Meijboom L; Houweling AC; Levy M; Antigny F; Chaouat A; Cottin V; Guignabert C; Coulet F; Sitbon O; Bonnet D; Humbert M; Montani D;
    Eur Respir J; 2024 Apr; 63(4):. PubMed ID: 38514094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
    Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
    Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity.
    Chomette L; Hupkens E; Romitti M; Dewachter L; Vachiéry JL; Bailly S; Costagliola S; Smits G; Tillet E; Bondue A
    Am J Med Genet A; 2023 Aug; 191(8):2064-2073. PubMed ID: 37249087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations.
    Balachandar S; Graves TJ; Shimonty A; Kerr K; Kilner J; Xiao S; Slade R; Sroya M; Alikian M; Curetean E; Thomas E; McConnell VPM; McKee S; Boardman-Pretty F; Devereau A; Fowler TA; Caulfield MJ; Alton EW; Ferguson T; Redhead J; McKnight AJ; Thomas GA; ; Aldred MA; Shovlin CL
    Am J Med Genet A; 2022 Mar; 188(3):959-964. PubMed ID: 34904380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report.
    Wang G; Fan R; Ji R; Zou W; Penny DJ; Varghese NP; Fan Y
    BMC Pulm Med; 2016 Jan; 16():17. PubMed ID: 26801773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis.
    Owen NE; Alexander GJ; Sen S; Bunclark K; Polwarth G; Pepke-Zaba J; Davenport AP; Morrell NW; Upton PD
    EBioMedicine; 2020 Jun; 56():102794. PubMed ID: 32454407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network.
    Choi H; Kim BG; Kim YH; Lee SJ; Lee YJ; Oh SP
    Angiogenesis; 2023 Feb; 26(1):167-186. PubMed ID: 36348215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP9 and BMP10: Two close vascular quiescence partners that stand out.
    Desroches-Castan A; Tillet E; Bouvard C; Bailly S
    Dev Dyn; 2022 Jan; 251(1):178-197. PubMed ID: 34240497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.
    Snodgrass RO; Chico TJA; Arthur HM
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia.
    Tillet E; Bailly S
    Front Genet; 2014; 5():456. PubMed ID: 25620979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
    Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
    J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the ALK1 ligands, BMP9 and BMP10.
    Li W; Salmon RM; Jiang H; Morrell NW
    Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous
    Liu J; Yang J; Tang X; Li H; Shen Y; Gu W; Zhao S
    Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32669404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia.
    Wooderchak-Donahue WL; McDonald J; O'Fallon B; Upton PD; Li W; Roman BL; Young S; Plant P; Fülöp GT; Langa C; Morrell NW; Botella LM; Bernabeu C; Stevenson DA; Runo JR; Bayrak-Toydemir P
    Am J Hum Genet; 2013 Sep; 93(3):530-7. PubMed ID: 23972370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the Evidence of a Semi-Dominant Inheritance in
    Gallego N; Cruz-Utrilla A; Guillén I; Bonora AM; Ochoa N; Arias P; Lapunzina P; Escribano-Subias P; Nevado J; Tenorio-Castaño J
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
    Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
    J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Modulating BMP9, BMPR2, and AQP1 on BMP Signaling in Human Pulmonary Microvascular Endothelial Cells.
    Lotsios NS; Keskinidou C; Dimopoulou I; Kotanidou A; Langleben D; Orfanos SE; Vassiliou AG
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.